Biogen Altman Z-Score
BIIB / Health Care|Modified Z-Score (book value) based on FY2025 data
Biogen's Altman Z-Score of 1.75 places the company in the "grey zone" used by the Altman model (1.23-2.9) for FY2025. Z-Score is calculated from 5 financial ratios derived from Biogen's SEC 10-K filing, evaluated in the context of the Health Care sector.
Based on SEC 10-K filings.
Key Data Points
- Cash-backed earnings: Operating cash flow exceeds net income
- Altman Z-Score 1.75 (gray zone, between 1.23 and 2.9)
Data sourced from SEC EDGAR filings. Not investment advice.
Grey Zone (1.23 - 2.9)
The score falls between the 1.23 and 2.9 boundaries used in the Altman model.
The Altman Z-Score uses 5 financial ratios. Learn more
Profit margin ranks in the below average of Health Care companies
Components: book value of equity, working capital, retained earnings, EBIT, and revenue-to-assets — all derived from SEC FY2025 10-K filings.
5-Factor Decomposition
Working Capital / Total Assets
- Ratio
- 0.191
- Weight
- 0.717
- Contribution
- 0.137
Retained Earnings / Total Assets
- Ratio
- 0.698
- Weight
- 0.847
- Contribution
- 0.591
EBIT / Total Assets
- Ratio
- -
- Weight
- 3.107
- Contribution
- -
Book Equity / Total Liabilities
- Ratio
- 1.633
- Weight
- 0.420
- Contribution
- 0.686
Revenue / Total Assets
- Ratio
- 0.336
- Weight
- 0.998
- Contribution
- 0.335
| Component | Ratio | Weight | Contribution |
|---|---|---|---|
| Working Capital / Total Assets | 0.191 | 0.717 | 0.137 |
| Retained Earnings / Total Assets | 0.698 | 0.847 | 0.591 |
| EBIT / Total Assets | - | 3.107 | - |
| Book Equity / Total Liabilities | 1.633 | 0.420 | 0.686 |
| Revenue / Total Assets | 0.336 | 0.998 | 0.335 |
| Total Z-Score | 1.75 | ||
As of FY2025 · SEC 10-K Annual Filings · Updated Mar 3, 2026
Z-Score Zones
Safe Zone - score above the 2.9 boundary used in the Altman model.
Grey Zone - score between the 1.23 and 2.9 boundaries used in the Altman model.
Distress Zone - score below the 1.23 boundary used in the Altman model.